Search
Patexia Research
Case number 1:18-cv-00497

Indivior Inc. et al v. Actavis Laboratories UT, Inc. > Documents

Date Field Doc. No.Description (Pages)
Jul 8, 2020 11 Motion for Leave to Appear Pro Hac Vice (1)
Jul 8, 2020 1 Complaint (7)
Sep 16, 2019 81 Order (4)
Docket Text: SO ORDERED re (71 in 18-cv-499-RGA; 80 in 18-cv-497-RGA) Stipulation and Order of Dismissal of Claims and Counterclaims (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/16/2019. Associated Cases: 1:18-cv-00497-RGA, 1:18-cv-00499-RGA(nms)
Sep 16, 2019 82 Patent/Trademark Report to Commissioner (1)
Sep 16, 2019 82 Order (4)
Sep 16, 2019 82 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,931,305 B2; 9,855,221 B2. (Attachments: # (1) Order)(nms)
Sep 13, 2019 80 Stipulation of Dismissal (4)
Docket Text: STIPULATION of Dismissal of Claims and Counterclaims, by Actavis Laboratories UT, Inc.. (Haney, Megan) Modified on 9/13/2019 (nms).
Aug 29, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [79] Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 8/29/2019. (nms)
Aug 28, 2019 79 Stipulation (2)
Docket Text: STIPULATION to Amend Scheduling Order by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
Aug 22, 2019 N/A SO ORDERED (0)
Aug 21, 2019 78 Stipulation (2)
Docket Text: STIPULATION and Proposed Order to Amend Scheduling Order by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
Aug 20, 2019 N/A SO ORDERED (0)
Aug 19, 2019 76 Notice (Other) (2)
Docket Text: NOTICE of Change of Address of Jamie Lucia of Steptoe & Johnson LLP by Aquestive Therapeutics, Inc. (Tigan, Jeremy)
Aug 19, 2019 77 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION to Amend Scheduling Order - filed by Aquestive Therapeutics, Inc., Indivior Inc.. (Tigan, Jeremy) Modified on 8/20/2019 (nms).
Jul 3, 2019 75 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Expert Report of James M. Rossman; (2) Expert Report of Graham Buckton, Ph.D.; and (2) Opening Expert Report of Maureen D. Donovan, Ph.D. filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Jun 20, 2019 N/A Order (0)
Jun 20, 2019 74 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION and Proposed Order to Amend Scheduling Order - filed by Actavis Laboratories UT, Inc.. (Haney, Megan) Modified on 6/20/2019 (nms).
May 22, 2019 73 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Indivior's First Supplemental Objections and Responses to Actavis' First Set of Interrogatories (Nos. 1-12), (2) Indivior's First Supplemental Objections and Responses to Actavis' First Set of Requests for Admission (Nos. 1-49), (3) Plaintiff Aquestive Therapeutics, Inc.'s First Supplemental Objections and Responses to Defendant's First Set of Requests for Admission (Nos. 1-49), and (4) Plaintiff Aquestive Therapeutics, Inc.'s First Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-12) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
May 17, 2019 N/A SO ORDERED (0)
May 16, 2019 72 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for various deadlines to various dates - filed by Actavis Laboratories UT, Inc.. (Phillips, John)
May 14, 2019 71 Memorandum Opinion (10)
Docket Text: MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent Nos. 9,931,305 and 9,687,454. Signed by Judge Richard G. Andrews on 5/14/2019. (nms)
May 9, 2019 N/A SO ORDERED (0)
May 8, 2019 70 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for defendant to raise any discovery disputes with respect to plaintiffs' discovery responses to defendant's First Set of Interrogatories and First Set of Requests for Admission to May 13, 2019 - filed by Actavis Laboratories UT, Inc.. (Phillips, John)
May 6, 2019 68 Notice to Take Deposition (2)
Docket Text: Amended NOTICE to Take Deposition of Garry Myers on May 8, 2019, filed by Actavis Laboratories UT, Inc..(Haney, Megan) Modified on 5/6/2019 (nms).
May 6, 2019 69 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Aquestive Therapeutics, Inc.'s Objections and Responses to Defendant's First Set of Requests for Admission (Nos. 1-49), (2) Plaintiff Aquestive Therapeutics, Inc.'s Objections and Responses to Defendant's First Set of Interrogatories, (3) Indivior's Objections and Responses to Actavis' First Set of Interrogatories (Nos. 1-12), and (4) Indivior's Objections and Responses to Actavis' First Set of Requests for Admission (Nos. 1-49) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 26, 2019 N/A SO ORDERED (0)
Apr 25, 2019 67 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Complete Fact Discovery - filed by Actavis Laboratories UT, Inc.. (Haney, Megan) Modified on 4/26/2019 (nms).
Apr 22, 2019 66 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Actavis Laboratories UT, Inc.'s Objections and Response to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Apr 17, 2019 64 Notice to Take Deposition (6)
Docket Text: NOTICE to Take Deposition of Garry Myers on April 26, 2019 filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Apr 17, 2019 65 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Indivior's Objections and Responses to Actavis' Amended Notice of Deposition of Indivior and Aquestive Pursuant o Fed. R. Civ. P. 30(b)(6) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 16, 2019 63 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Aquestive Therapeutics, Inc.'s Objections to Defendant's Notice of Deposition of Madhu Hariharan and (2) Aquestive's Objections and Responses to Defendant's Notice of Deposition Pursuant to Fed. R. Civ. Proc. 30(b)(6) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 12, 2019 62 Notice to Take Deposition (7)
Docket Text: Amended NOTICE to Take Deposition of Plaintiffs Indivior Inc., Indivior UK Limited and Aquestive Therapeutics, Inc. Pursuant to Fed. R. Civ. Proc. 30(b)(6) on April 30, 2019, filed by Actavis Laboratories UT, Inc..(Haney, Megan) Modified on 4/15/2019 (nms).
Apr 10, 2019 59 Notice to Take Deposition (9)
Docket Text: NOTICE to Take Deposition of Actavis Laboratories UT, Inc. on April 30, 2019 filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 10, 2019 60 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Brandee Morgan on April 23, 2019 filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 10, 2019 61 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Tate Edwards on April 22, 2019 filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Apr 9, 2019 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The date of the teleconference in DI 58 is 7/23/19 at 5:00 p.m. not 4/23/19. (cak)
Apr 9, 2019 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference: A Telephone Conference is set for 7/23/2019 at 5:00 PM Eastern Time with Judge Thynge. Counsel for defendant shall initiate the teleconference. In addition, counsel for Indivior shall provide a copy of the Federal Circuit decision in a related matter and Judge Andrews' claim construction opinion when issued. These opinions may be emailed to Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy. Ordered by Judge Mary Pat Thynge on 4/9/19. (cak) Modified on 4/9/2019 (cak).
Mar 29, 2019 57 Notice to Take Deposition (6)
Docket Text: NOTICE to Take Deposition of Madhu Hariharan on April 17, 2019 filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Mar 28, 2019 54 Notice to Take Deposition (7)
Docket Text: NOTICE to Take Deposition of Indivior Inc., Indivior UK Limited and Aquestive Therapeutics, Inc. [Pursuant to Fed. R. Civ. P. 30(b)(6)] on April 16, 2019 filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Mar 28, 2019 55 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Garry Myers on April 15, 2019 filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Mar 28, 2019 56 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Defendant Actavis Laboratories UT, Inc.'s First Set of Interrogatories to Plaintiffs; and (2) Defendant Actavis Laboratories UT, Inc.'s First Set of Requests for Admission to Plaintiffs filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Mar 15, 2019 53 Transcript (60)
Docket Text: Official Transcript of Markman Hearing held on 3/6/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather Triozzi/Dale Hawkins,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/5/2019. Redacted Transcript Deadline set for 4/15/2019. Release of Transcript Restriction set for 6/13/2019. (Triozzi, Heather)
Mar 6, 2019 N/A Markman Hearing (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 3/6/2019. Counsel Present for Plaintiffs: J. Blumenfeld. Counsel present for Defendant: D. Bilson. (Court Reporter Heather Triozzi, Dale Hawkins.) (crb)
Mar 5, 2019 52 Claim Construction Chart (11)
Docket Text: Second Amendment to Joint Construction Chart, by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy) Modified on 3/6/2019 (nms).
Mar 1, 2019 N/A CORRECTING ENTRY: (0)
Mar 1, 2019 N/A SO ORDERED (0)
Mar 1, 2019 50 Motion for Leave to Appear Pro Hac Vice (7)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan, Jeffrey H. Lerner, Erica N. Andersen, and Philip S. May - filed by Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
Mar 1, 2019 51 Claim Construction Chart (11)
Docket Text: Amendment to Joint Claim Construction Chart, by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy) Modified on 3/1/2019 (nms).
Feb 19, 2019 48 Redacted Document (30)
Docket Text: REDACTED VERSION of [46] Joint Claim Construction Brief, by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy) Modified on 2/19/2019 (nms).
Feb 19, 2019 49 Redacted Document (30)
Docket Text: REDACTED VERSION of [47] Appendix by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
Feb 14, 2019 N/A CORRECTING ENTRY: (0)
Feb 8, 2019 45 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis' Sur-Reply Brief in Support of its Answering Claim Construction Brief filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Jan 25, 2019 44 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Jan 24, 2019 N/A SO ORDERED (0)
Jan 23, 2019 43 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to Serve Reply and Sur-Reply Claim Construction Briefs to January 25, 2019 and February 8, 2019 - filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
Dec 21, 2018 42 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis' Answering Brief to Plaintiffs' Opening Claim Construction Brief filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Dec 14, 2018 41 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-2) filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Dec 11, 2018 N/A Order Setting Teleconference (0)
Dec 7, 2018 39 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Aquestive Therapeutics, Inc.'s Objections and Responses to Actavis's First Set of Requests for Production (Nos. 1-60) and (2) Indivior's Objections and Responses to Actavis' First Set of Requests for Production (Nos. 160) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Nov 20, 2018 38 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Nov 14, 2018 37 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendant Actavis Laboratories UT, Inc. (Nos. 1-2) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Blumenfeld, Jack)
Oct 31, 2018 36 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s First Set of Requests for Production of Documents Pursuant to Rule 34 (Nos. 1-60) to Plaintiffs filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Oct 29, 2018 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney James F. Hibey for Aquestive Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Oct 26, 2018 N/A Add Attorneys Pro Hac Vice (0)
Oct 19, 2018 35 Claim Construction Chart (3)
Oct 19, 2018 35 Exhibit A (9)
Oct 19, 2018 35 Exhibits B-I (202)
Oct 19, 2018 35 Exhibits J-O (287)
Oct 19, 2018 35 Main Document (3)
Docket Text: Joint Claim Construction Statement, by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Attachments: # (1) Exhibit A, # (2) Exhibits B-I, # (3) Exhibits J-O)(Tigan, Jeremy) Modified on 10/19/2018 (nms).
Oct 15, 2018 34 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Identification of Extrinsic and Intrinsic Evidence To Oppose Plaintiffs' Proposed Claim Constructions filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Sep 24, 2018 33 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Preliminary Proposed Constructions filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Sep 12, 2018 32 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Proposed Claim Terms for Construction filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Sep 5, 2018 31 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Initial Invalidity Contentions filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Aug 27, 2018 30 Notice Requesting Removal of Co-Counsel (2)
Docket Text: NOTICE requesting Clerk to remove Daniel A. Ladow, James M. Bollinger, Timothy P. Heaton, J. Magnus Essunger, Gerald E. Porter, Charanjit Brahma, Sujatha Vathyam, and Daniel Sharpe as co-counsel. Reason for request: no longer associated with the action. (Tigan, Jeremy)
Aug 24, 2018 N/A Oral Order (0)
Docket Text: ORAL ORDER Setting Teleconference: Defense Counsel to initiate the call. A Telephone Conference is set for Tuesday, 12/11/2018 at 12:00 noon Eastern Time before Judge Mary Pat Thynge. The purpose of the Telephone Conference is to discuss the status of the case and its effect on mediation. Ordered by Judge Mary Pat Thynge on 8/24/2018. (fms)
Aug 7, 2018 28 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Charts filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Jul 23, 2018 27 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents Pursuant to Rule 34 (Nos. 1-42) filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Jul 10, 2018 25 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Delaware Default Standard for Discovery, Paragraph 3 filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Jul 10, 2018 26 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Actavis Laboratories UT, Inc.'s Rule 26(a)(1) Initial Disclosures; and (2) Actavis Laboratories UT, Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Actavis Laboratories UT, Inc..(Haney, Megan)
Jun 28, 2018 23 Proposed Order (29)
Docket Text: PROPOSED Stipulated Protective Order, by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited. (Tigan, Jeremy) Modified on 6/28/2018 (nms).
Jun 28, 2018 24 Order (29)
Docket Text: SO ORDERED Granting [23] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 6/28/2018. (nms)
Jun 22, 2018 22 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production Pursuant to Rule 34 (Nos 1-42) filed by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Blumenfeld, Jack)
Jun 21, 2018 21 Answer to Counterclaim (8)
Docket Text: ANSWER to [14] Answer to Amended Complaint, Counterclaim by Aquestive Therapeutics, Inc., Indivior Inc., Indivior UK Limited.(Tigan, Jeremy)
Jun 13, 2018 19 Scheduling Order (12)
Docket Text: SCHEDULING ORDER: These actions are consolidated for all purposes, and all papers shall be filed in C.A. No. 18-497-RGA. Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2018. Amended Pleadings due by 9/10/2018. Discovery due by 4/30/2019. Joint Claim Construction Brief due by 2/13/2019. A Markman Hearing is set for 3/6/2019, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 12/6/2019, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A Bench Trial is set for 12/16/2019, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 6/13/2018. Associated Cases: 1:18-cv-00497-RGA, 1:18-cv-00499-RGA(nms)
Jun 13, 2018 20 Order Setting Teleconference (4)
Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 8/23/2018 at 11:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 6/13/18. Associated Cases: 1:18-cv-00497-RGA, 1:18-cv-00499-RGA(cak)
Jun 12, 2018 18 Proposed Order (12)
Jun 12, 2018 18 Letter (1)
Jun 12, 2018 18 Main Document (12)
Docket Text: PROPOSED Scheduling Order, by Indivior Inc., Indivior UK Limited, Aquestive Therapeutics, Inc.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 6/13/2018 (nms).
Jun 11, 2018 N/A Add Attorneys Pro Hac Vice (0)
Jun 10, 2018 17 Transcript (19)
Docket Text: Official Transcript of Scheduling Conference held on 06-08-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/2/2018. Redacted Transcript Deadline set for 7/11/2018. Release of Transcript Restriction set for 9/10/2018. (lad)
Jun 8, 2018 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 6/8/2018. Counsel for plaintiff to submit a revised Order with agreed upon dates. (Court Reporter Leonard Dibbs.) Associated Cases: 1:18-cv-00497-RGA, 1:18-cv-00499-RGA(ksr, )
Jun 6, 2018 N/A Add Attorneys Pro Hac Vice (0)
Jun 6, 2018 16 Proposed Order (13)
Jun 6, 2018 16 Chart (3)
Jun 6, 2018 16 Main Document (13)
Docket Text: PROPOSED Scheduling Order, by Indivior Inc., Indivior UK Limited, Aquestive Therapeutics, Inc.. (Attachments: # (1) Chart)(Tigan, Jeremy) Modified on 6/6/2018 (nms).
May 31, 2018 N/A SO ORDERED (0)
May 31, 2018 N/A SO ORDERED (0)
May 31, 2018 N/A Add Attorneys Pro Hac Vice (0)
May 31, 2018 13 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James Francis Hibey and Jamie Lucia - filed by Aquestive Therapeutics, Inc.. (Tigan, Jeremy)
May 31, 2018 14 Answer to Amended Complaint (17)
Docket Text: ANSWER to [6] Amended Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs by Actavis Laboratories UT, Inc..(Phillips, John) Modified on 5/31/2018 (nms).
May 31, 2018 15 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis Laboratories UT, Inc. filed by Actavis Laboratories UT, Inc.. (Phillips, John)
May 30, 2018 12 Motion for Leave to Appear Pro Hac Vice (10)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel A. Ladow, James M. Bollinger, Charanjit Brahma, Timothy P. Heaton, J. Magnus Essunger, Sujatha Vathyam, Daniel Sharpe, and Gerald E. Porter - filed by Indivior Inc., Indivior UK Limited. (Tigan, Jeremy)
May 18, 2018 N/A Add Attorneys Pro Hac Vice (0)
May 17, 2018 N/A SO ORDERED (0)
May 16, 2018 11 Nutter Pro Hac Certification (1)
May 16, 2018 11 Smerek Pro Hac Certification (1)
May 16, 2018 11 Dalke Pro Hac Certification (1)
May 16, 2018 11 Main Document (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter, Stephen R. Smerek and David P. Dalke, Ph.D. - filed by Actavis Laboratories UT, Inc.. (Attachments: # (1) Nutter Certification, # (2) Smerek Certification, # (3) Dalke Certification)(Phillips, John) Modified on 5/17/2018 (nms).
May 15, 2018 10 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 6/8/2018, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 5/15/2018. (nms)
May 14, 2018 8 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by John C. Phillips, Jr on behalf of Actavis Laboratories UT, Inc. (Phillips, John)
May 14, 2018 9 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Actavis Laboratories UT, Inc. (Haney, Megan)
Apr 30, 2018 6 Amended Complaint (9)
Apr 30, 2018 6 Exhibits A-B (118)
Apr 30, 2018 7 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,931,305 B2 ;US 9,855,221 B2. (Tigan, Jeremy) Modified on 5/1/2018 (nms).
Apr 30, 2018 6 Main Document (9)
Docket Text: First Amended Complaint for Patent Infringement against Actavis Laboratories UT, Inc. - filed by Indivior UK Limited, Indivior Inc., Aquestive Therapeutics, Inc.. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) Modified on 5/1/2018 (nms).
Apr 30, 2018 6 Amended Complaint* (1)
Apr 11, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Apr 4, 2018 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Actavis Laboratories UT, Inc. on 4/4/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms)
Apr 3, 2018 1 Exhibit A (82)
Apr 3, 2018 1 Civil Cover Sheet (1)
Apr 3, 2018 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms)
Apr 3, 2018 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 2/14/2022. Thirty Month Stay Deadline: N/A. (fms)
Apr 3, 2018 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,931,305 B2. (fms)
Apr 3, 2018 5 Disclosure Statement (3)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Indivior US Holdings Inc., identifying Corporate Parent Indivior Finance LLC, identifying Corporate Parent Indivior PLC, Corporate Parent Indivior Global Holdings Limited, identifying Corporate Parent RBP Global Holdings Limited, Other Affiliate Schroders Capital Management for Indivior Inc. Identifying Corporate Parent RBP Global Holdings Limited, Corporate Parent Indivior Global Holdings Limited, Corporate Parent Indivior PLC, and Other Affiliate Schroders Capital Management for Indivior UK Limited. No Corporate Parent for Aquestive Therapeutics, Inc (fms)
Apr 3, 2018 1 Main Document (7)
Docket Text: COMPLAINT for Patent Infringement filed against Actavis Laboratories UT, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2353967.) - filed by Indivior UK Limited, Indivior Inc., Aquestive Therapeutics, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(fms)
Apr 3, 2018 1 Complaint* (1)
Menu